Principal Jessica Cook recognized the outstanding academic achievements of Shawsheen Valley Technical High School students ...

This article first appeared in Wildfire magazine. The Pedrógão Grande mega fire of June 2017 shaped a region by tragedy, ...

Haverhill High School this week released its second term honor roll, naming students who have earned Honors with Distinction, ...

Credit cards aren't just about spending. They are also powerful tools that, when used wisely, can help you save money, manage ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

Lily Allen is sharing details surrounding a recent visit to a treatment center. The singer discussed the visit on the latest episode of her BBC podcast “Miss Me?” with her cohost Miquita ...

42,045 people played the daily Crossword recently. Can you solve it faster than others?42,045 people played the daily Crossword recently. Can you solve it faster than others? Tom Hanks & Rita ...

Boris Becker's ex-wife Lilly has won the German version of I'm A Celebrity... Get Me Out Of Here! after stealing the hearts of the nation. The former Wimbledon tennis star, 57, has endured a ...

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price target of $1,146.00. The company’s shares closed ...

Eli Lilly LLY-N on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about signs of weakness in sales of the drugs.